These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 27896271)
21. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy. Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641 [TBL] [Abstract][Full Text] [Related]
23. High-expression of lncRNA CEBPA-AS1 promotes liver cancer progression. Wu C; Tang ZY; Chen HY; Zhang J; Zhao C Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8295-8302. PubMed ID: 31646559 [TBL] [Abstract][Full Text] [Related]
24. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Li B; Mao R; Liu C; Zhang W; Tang Y; Guo Z Life Sci; 2018 Mar; 197():122-129. PubMed ID: 29421439 [TBL] [Abstract][Full Text] [Related]
25. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21. Wei C; Wang H; Xu F; Liu Z; Jiang R Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433 [TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713 [TBL] [Abstract][Full Text] [Related]
27. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma. Lu X; Zhou C; Li R; Liang Z; Zhai W; Zhao L; Zhang S Tumour Biol; 2016 Jul; 37(7):9699-707. PubMed ID: 26803513 [TBL] [Abstract][Full Text] [Related]
28. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells. Liu W; Huai R; Zhang Y; Rao S; Xiong L; Ding R; Mao C; Zhao W; Hao T; Huang Q; Guo Z Genes Genomics; 2019 Aug; 41(8):951-959. PubMed ID: 31066006 [TBL] [Abstract][Full Text] [Related]
30. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma. Sheng N; Li Y; Qian R; Li Y Biomed Pharmacother; 2018 Feb; 98():577-584. PubMed ID: 29288973 [TBL] [Abstract][Full Text] [Related]
31. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of POLH-AS1 as a prognostic biomarker in hepatocellular carcinoma. Dong Y; Chen X; Yang S; Fu Y; Wang L; Gao X; Chen D; Xu L BMC Cancer; 2024 Sep; 24(1):1112. PubMed ID: 39242532 [TBL] [Abstract][Full Text] [Related]
33. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
34. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma. Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902 [TBL] [Abstract][Full Text] [Related]
35. The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma. Qi HL; Li CS; Qian CW; Xiao YS; Yuan YF; Liu QY; Liu ZS Tumour Biol; 2016 Jan; 37(1):1079-89. PubMed ID: 26271667 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537 [TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway. Zhuang J; He S; Wang G; Wang G; Ni J; Zhang S; Ye Y; Xia W Oncol Res; 2018 Sep; 26(8):1257-1265. PubMed ID: 29463348 [TBL] [Abstract][Full Text] [Related]
38. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer. Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877 [TBL] [Abstract][Full Text] [Related]
39. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103. Ma CX; Gao WC; Tian L Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297 [TBL] [Abstract][Full Text] [Related]
40. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. Tu ZQ; Li RJ; Mei JZ; Li XH Int J Clin Exp Pathol; 2014; 7(7):4303-9. PubMed ID: 25120813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]